Clinical Trial Update: Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing NN5401 with insulin glargine in insulin-naive adults with type 2 diabetes. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• NN5401

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-23